The UK HIV Drug Resistance Database: development and use for national surveillance. 12th International HIV Drug Resistance Workshop, 10-14 June 2003.. 2003.
Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom. J Infect Dis. 192:967-73.. 2005.
Estimating resistance in drug experienced patients in the UK. 13th International Drug Resistance Workshop, 8-12 June 2004.. 2004.
The biology, epidemiology and clinical implications of transmitted HIV drug resistant viruses. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.. 2009.
An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput Biol. 5:e1000581.. 2009.
Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo data. Antivir Ther. 15:203-11.. 2010.
Positive and negative drug selection pressures on the N348I connection domain mutation; new insights from in vivo data. 18th International HIV Drug Resistance Workshop, June 2009.. 2009.
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study. J Antimicrob Chemother. 66:1886-96.. 2011.
Nondisclosed MSM link together in HIV transmission networks. 24th International HIV Dynamics and Evolution.. 2017.
Dynamics of Non-B HIV Transmission in the UK. 20th Conference on Retroviruses and Opportunistic Infections, 3-6 March 2013.. 2013.
Non-disclosed men who have sex with men in UK HIV transmission networks: phylogenetic analysis of surveillance data.. Lancet HIV. 5(6):e309-e316.. 2018.
Transmission of Non-B HIV Subtypes in the United Kingdom Is Increasingly Driven by Large Non-Heterosexual Transmission Clusters. J Infect Dis. 213:1410-8.. 2016.
Non-B HIV transmission networks in the UK. 20th International HIV Dynamics & Evolution Conference, 8-11 May 2013.. 2013.
Automated Analysis of A1 cluster dynamics in the UK 2007-2010. 19th International HIV Dynamics & Evolution Conference, 25-28 April 2012.. 2012.
Automated analysis of phylogenetic clusters. BMC Bioinformatics. 14:317.. 2013.
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues. HIV Med. 14:571-7.. 2013.
Different drug-resistance development in HIV-1 infected patients failing a first-line antiretroviral therapy containing NNRTIs. IAS, 17-20 July 2011.. 2011.